(Q44857535)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15543200%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

title

Prognostic factors for survival after autologous transplantation: a single centre experience in 133 multiple myeloma patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15543200%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15543200%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Roman Hajek

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15543200%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Krejci M

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15543200%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Svobodnik A

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15543200%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Krivanova A

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15543200%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Pour L

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15543200%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Adam Z

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15543200%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Mayer J

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15543200%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Vorlicek J

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15543200%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

language of work or name

English

0 references

publication date

1 January 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15543200%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

5 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15543200%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15543200%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15543200%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

159-164

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15543200%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

cites work

Cancer statistics, 2000.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704728

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704728

A prognostic index for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704728

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704728

Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704728

Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704728

Autologous stem cell transplantation in multiple myeloma: improved survival in nonsecretory multiple myeloma but lack of influence of age, status at transplant, previous treatment and conditioning regimen. A single-centre experience in 127 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704728

Autologous peripheral blood stem cell transplantation for multiple myeloma: a report of 259 cases from the Spanish Registry. Spanish Registry for Transplant in MM (Grupo Español de Trasplante Hematopoyético-GETH) and PETHEMA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704728

European Group for Blood and Marrow Transplantation Registry studies in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704728

The role of autologous transplantation in patients with multiple myeloma aged 65 years and over

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704728

Controversy in multiple myeloma transplants: tandem autotransplants and mini-allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704728

Intensive chemotherapy with blood progenitor transplantation for primary resistant multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704728

Long-term follow-up after high-dose therapy for high-risk multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704728

The role of stem cell transplantation in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704728

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704728

7 January 2021

Prognostic factors in low tumour mass asymptomatic multiple myeloma: a report on 91 patients. The Groupe d'Etudes et de Recherche sur le Myélome (GERM)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704728

7 January 2021

Predicting long-term (> or = 5 years) event-free survival in multiple myeloma patients following planned tandem autotransplants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704728

7 January 2021

High-dose therapy with peripheral blood progenitor cell transplantation in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704728

7 January 2021

Autologous bone marrow and peripheral blood stem cell transplantation in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704728

7 January 2021

High-dose melphalan with autotransplantation for refractory multiple myeloma: results of a Southwest Oncology Group phase II trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704728

7 January 2021

Effect of complete response on outcome following autologous stem cell transplantation for myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704728

7 January 2021